Table 1.
Participants (n = 25) | Non-participants (n= 59) | |
---|---|---|
Median age (range) in years | 18 (8–33) | 18 (3–34) |
Gender | ||
Male | 19 | 30 |
Female | 6 | 29 |
Malignancy | ||
Precursor-B-ALL | 17 | 46 |
T-ALL | 6 | 9 |
Unclassified | 2 | 4 |
Median age at SCT (range) | 11 (2–18) | 7 (1–18) |
Source of stem cells | ||
Bone marrow | 17 | 38 |
Peripheral blood stem cells | 8 | 21 |
Donor | ||
Related | 4 | 22 |
Unrelated | 21 | 37 |
Stage of disease | ||
CR1 | 16 | 18 |
CR2 | 9 | 36 |
CR3 | - | 5 |
Ratio male: female of participants was 3.2:1 in comparison to all eligible subjects of 1.4:1. The ratio CR:CR2 of participants was 1.77:1 in comparison to all eligible subjects of 0.74:1